These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 31109863

  • 1. Medication-related osteonecrosis of the jaw: A literature review.
    Kuroshima S, Sasaki M, Sawase T.
    J Oral Biosci; 2019 Jun; 61(2):99-104. PubMed ID: 31109863
    [Abstract] [Full Text] [Related]

  • 2. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S, Sasaki M, Murata H, Sawase T.
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [Abstract] [Full Text] [Related]

  • 3. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M, Kuroshima S, Sawase T.
    Int J Implant Dent; 2021 May 14; 7(1):47. PubMed ID: 33987769
    [Abstract] [Full Text] [Related]

  • 4. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T.
    Tohoku J Exp Med; 2019 Feb 14; 247(2):75-86. PubMed ID: 30713280
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Risk of Medication-Related Osteonecrosis of the Jaw in Children: Guidance for Antiresorptive Use in Pediatric Patients.
    Lasky S, Moshal T, Shakoori P, Roohani I, Jolibois M, Youn S, Urata MM, Hammoudeh JA.
    J Oral Maxillofac Surg; 2024 Oct 14; 82(10):1285-1294. PubMed ID: 38950582
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug 14; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 12. Antiresorptive treatment-associated ONJ.
    Eleutherakis-Papaiakovou E, Bamias A.
    Eur J Cancer Care (Engl); 2017 Nov 14; 26(6):. PubMed ID: 29063702
    [Abstract] [Full Text] [Related]

  • 13. Emerging antiresorptive medications and their potential implications for dental surgeries.
    Aminoshariae A, Donaldson M, Horan M, Mackey SA, Kulild JC, Baur D.
    J Am Dent Assoc; 2022 Jul 14; 153(7):649-658. PubMed ID: 35277242
    [Abstract] [Full Text] [Related]

  • 14. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B, Muschitz Ch, Gruber R, Brandtner Ch, Svejda Ch, Gasser RW, Santler G, Dimai HP.
    Wien Med Wochenschr; 2016 Feb 14; 166(1-2):68-74. PubMed ID: 26847441
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Dental Implant Treatment in Patients Receiving Anti-resorptive Agents.].
    Kuroshima S.
    Clin Calcium; 2017 Feb 14; 27(10):1453-1459. PubMed ID: 28947697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.